Published 2002 | Version v1.0.0
Journal Article Open

Randomized, Controlled Study of Adderall XR in ADHD

Abstract

The efficacy and safety of Adderall XR in the treatment of attention deficit/hyperactivity disorder and diurnal variation in responses were assessed by a multicenter, randomized, double-blind, parallel group, placebo-controlled trial at 47 sites, and reported from the Massachusetts General Hospital, Boston, MA.

Files

PNB-16-64-b.pdf

Files (1.6 MB)

Name Size Download all
md5:94015529b20dafe253da8ea1aa69079f
1.6 MB Preview Download

Additional details

Identifiers

Other
PNB-16-64-b

Dates

Created
2002
When the item was originally created.